[The renin-angiotensin system].
Hilgers
K F
KF
Medizinische Klinik, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen. karl.hilgers@uk-erlangen.de
D000450:Aldosterone / Q000502:physiology; D000804:Angiotensin II / Q000502:physiology; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001158:Arteries / Q000503:physiopathology*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology*; D007249:Inflammation / Q000503:physiopathology*; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D008955:Models, Cardiovascular; D012083:Renin / Q000502:physiology; D012084:Renin-Angiotensin System / Q000502:physiology*; D000092502:Renin Inhibitors
D000450:Aldosterone; D000804:Angiotensin II; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000451:Mineralocorticoid Receptor Antagonists; D012083:Renin; D000092502:Renin Inhibitors